title: Respiratory syncytial virus and other respiratory viruses in the setting of bone marrow transplantation.
abstract: OBJECTIVE
  Several epidemiologic studies have enhanced our understanding of the impact of respiratory viruses on bone marrow transplant recipients.
  
  
  RESULTS
  Respiratory viral infections occur frequently following stem cell transplantation but present atypically. Many patients have asymptomatic infections. There is a growing armamentarium of antiviral agents currently under development, although prospective studies in transplant patients are needed.
  
  
  CONCLUSIONS
  Respiratory viral infections occur frequently after hematopoietic stem cell transplant. Newer agents may prove useful in the prevention and treatment of respiratory viral infections in this population.
authors.affiliation: Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. mgison@northwestern.edu
authors.forename: Michael G
authors.initials: MG
authors.lastname: Ison
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006801:Humans; D018186:Pneumovirus Infections / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D011183:Postoperative Complications / Q000188:drug therapy; D018113:Respiratory Syncytial Virus, Human; D018108:Respirovirus
chemical_list: D000998:Antiviral Agents